Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.
作者:
主题词
抗风湿药(Antirheumatic Agents);关节炎, 类风湿(Arthritis, Rheumatoid);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);药物疗法, 联合(Drug Therapy, Combination);杂环化合物, 3环(Heterocyclic Compounds, 3-Ring);人类(Humans);甲氨蝶呤(Methotrexate);哌啶类(Piperidines);嘧啶类(Pyrimidines);吡咯类(Pyrroles);生活质量(Quality of Life);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome)
DOI
10.1007/s12325-021-01930-4
PMID
34636000
发布时间
2022-05-31
- 浏览0

Advances in therapy
5649-5661页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文